{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T10:06:18Z","timestamp":1772273178120,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T00:00:00Z","timestamp":1461974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2015065926"],"award-info":[{"award-number":["2015065926"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002560","name":"Soonchunhyang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11255-016-1295-y","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T02:50:37Z","timestamp":1461984637000},"page":"1215-1227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Efficacy and safety of botulinum toxin injection for interstitial cystitis\/bladder pain syndrome: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"48","author":[{"given":"Sung Ryul","family":"Shim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Joo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Soo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Heon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,30]]},"reference":[{"issue":"4","key":"1295_CR1","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/nau.20687","volume":"28","author":"P Hanno","year":"2009","unstructured":"Hanno P, Dmochowski R (2009) Status of international consensus on interstitial cystitis\/bladder pain syndrome\/painful bladder syndrome: 2008 snapshot. Neurourol Urodyn 28(4):274\u2013286. doi: 10.1002\/nau.20687","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"1295_CR2","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.3390\/toxins7062232","volume":"7","author":"JF Jhang","year":"2015","unstructured":"Jhang JF, Kuo HC (2015) Novel Treatment of Chronic Bladder Pain Syndrome and Other Pelvic Pain Disorders by OnabotulinumtoxinA injection. Toxins 7(6):2232\u20132250. doi: 10.3390\/toxins7062232","journal-title":"Toxins"},{"issue":"5","key":"1295_CR3","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.juro.2015.01.086","volume":"193","author":"PM Hanno","year":"2015","unstructured":"Hanno PM, Erickson D, Moldwin R, Faraday MM, American Urological A (2015) Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome: AUA guideline amendment. J Urol 193(5):1545\u20131553. doi: 10.1016\/j.juro.2015.01.086","journal-title":"J Urol"},{"issue":"1","key":"1295_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.eururo.2008.09.009","volume":"55","author":"A Apostolidis","year":"2009","unstructured":"Apostolidis A, Dasgupta P, Denys P, Elneil S, Fowler CJ, Giannantoni A, Karsenty G, Schulte-Baukloh H, Schurch B, Wyndaele JJ, European Consensus P (2009) Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. Eur Urol 55(1):100\u2013119. doi: 10.1016\/j.eururo.2008.09.009","journal-title":"Eur Urol"},{"issue":"6","key":"1295_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/ncpuro1124","volume":"5","author":"MB Chancellor","year":"2008","unstructured":"Chancellor MB, Fowler CJ, Apostolidis A, de Groat WC, Smith CP, Somogyi GT, Aoki KR (2008) Drug Insight: biological effects of botulinum toxin A in the lower urinary tract. Nat Clin Pract Urol 5(6):319\u2013328. doi: 10.1038\/ncpuro1124","journal-title":"Nat Clin Pract Urol"},{"issue":"8","key":"1295_CR6","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1464-410X.2010.09317.x","volume":"105","author":"YC Chuang","year":"2010","unstructured":"Chuang YC, Kuo HC, Chancellor MB (2010) Botulinum toxin for the lower urinary tract. BJU Int 105(8):1046\u20131058","journal-title":"BJU Int"},{"issue":"17","key":"1295_CR7","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1056\/NEJM199104253241707","volume":"324","author":"J Jankovic","year":"1991","unstructured":"Jankovic J, Brin MF (1991) Therapeutic uses of botulinum toxin. N Engl J Med 324(17):1186\u20131194. doi: 10.1056\/NEJM199104253241707","journal-title":"N Engl J Med"},{"issue":"5","key":"1295_CR8","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.juro.2015.01.087","volume":"193","author":"EA Gormley","year":"2015","unstructured":"Gormley EA, Lightner DJ, Faraday M, Vasavada SP, American Urological A, American Urological A, Society of Urodynamics FPM (2015) Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline amendment. J Urol 193(5):1572\u20131580","journal-title":"J Urol"},{"issue":"3","key":"1295_CR9","first-page":"197","volume":"15","author":"SD Chung","year":"2012","unstructured":"Chung SD, Kuo YC, Kuo HC (2012) Intravesical onabotulinumtoxinA injections for refractory painful bladder syndrome. Pain Phys 15(3):197\u2013202","journal-title":"Pain Phys"},{"issue":"4","key":"1295_CR10","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.eururo.2005.12.002","volume":"49","author":"A Giannantoni","year":"2006","unstructured":"Giannantoni A, Costantini E, Di Stasi SM, Tascini MC, Bini V, Porena M (2006) Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study. Eur Urol 49(4):704\u2013709. doi: 10.1016\/j.eururo.2005.12.002","journal-title":"Eur Urol"},{"issue":"3","key":"1295_CR11","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.juro.2007.10.032","volume":"179","author":"A Giannantoni","year":"2008","unstructured":"Giannantoni A, Porena M, Costantini E, Zucchi A, Mearini L, Mearini E (2008) Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup. J Urol 179(3):1031\u20131034. doi: 10.1016\/j.juro.2007.10.032","journal-title":"J Urol"},{"issue":"5","key":"1295_CR12","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1464-410X.2009.08495.x","volume":"104","author":"HC Kuo","year":"2009","unstructured":"Kuo HC, Chancellor MB (2009) Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis\/painful bladder syndrome. BJU Int 104(5):657\u2013661. doi: 10.1111\/j.1464-410X.2009.08495.x","journal-title":"BJU Int"},{"key":"1295_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/nau.22760","author":"HC Kuo","year":"2015","unstructured":"Kuo HC, Jiang YH, Tsai YC, Kuo YC (2015) Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis\/bladder pain syndrome refractory to conventional treatment\u2014a prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial. Neurourol Urodyn. doi: 10.1002\/nau.22760","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"1295_CR14","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/j.1464-410X.2012.11466.x","volume":"111","author":"JH Shie","year":"2013","unstructured":"Shie JH, Liu HT, Wang YS, Kuo HC (2013) Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis\/bladder pain syndrome. BJU Int 111(4):638\u2013646. doi: 10.1111\/j.1464-410X.2012.11466.x","journal-title":"BJU Int"},{"issue":"1","key":"1295_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/nau.20946","volume":"30","author":"HP Gottsch","year":"2011","unstructured":"Gottsch HP, Miller JL, Yang CC, Berger RE (2011) A pilot study of botulinum toxin for interstitial cystitis\/painful bladder syndrome. Neurourol Urodyn 30(1):93\u201396. doi: 10.1002\/nau.20946","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"1295_CR16","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00192-013-2267-8","volume":"25","author":"J Manning","year":"2014","unstructured":"Manning J, Dwyer P, Rosamilia A, Colyvas K, Murray C, Fitzgerald E (2014) A multicentre, prospective, randomised, double-blind study to measure the treatment effectiveness of abobotulinum A (AboBTXA) among women with refractory interstitial cystitis\/bladder pain syndrome. Int Urogynecol J 25(5):593\u2013599. doi: 10.1007\/s00192-013-2267-8","journal-title":"Int Urogynecol J"},{"issue":"3","key":"1295_CR17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177\u2013188","journal-title":"Control Clin Trials"},{"issue":"7","key":"1295_CR18","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine 6(7):e1000097. doi: 10.1371\/journal.pmed.1000097","journal-title":"PLoS medicine"},{"issue":"4 suppl. 1","key":"1295_CR19","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1016\/j.juro.2012.02.912","volume":"187","author":"G Kasyan","year":"2012","unstructured":"Kasyan G, Pushkar D (2012) Randomized controlled trial for efficacy of botulinum toxin type a in treatment of patients suffering bladder pain syndrome\/interstitial cystitis with hunners\u2019 lesions: preliminary results. J Urol 187(4 suppl. 1):e335\u2013e336. doi: 10.1016\/j.juro.2012.02.912","journal-title":"J Urol"},{"issue":"6 Pt 1","key":"1295_CR20","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.juro.2006.07.127","volume":"176","author":"YC Chuang","year":"2006","unstructured":"Chuang YC, Chancellor MB (2006) The application of botulinum toxin in the prostate. The Journal of urology 176(6 Pt 1):2375\u20132382. doi: 10.1016\/j.juro.2006.07.127","journal-title":"The Journal of urology"},{"issue":"4","key":"1295_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/MOU.0b013e32832ae176","volume":"19","author":"CM Silva da","year":"2009","unstructured":"da Silva CM, Cruz F (2009) Has botulinum toxin therapy come of age: what do we know, what do we need to know, and should we use it? Curr Opin Urol 19(4):347\u2013352. doi: 10.1097\/MOU.0b013e32832ae176","journal-title":"Curr Opin Urol"},{"issue":"6","key":"1295_CR22","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1080\/03610926.2010.535631","volume":"41","author":"E Demidenko","year":"2012","unstructured":"Demidenko E, Sargent J, Onega T (2012) Random effects coefficient of determination for mixed and meta-analysis models. Commun Stat Theory Methods 41(6):953\u2013969. doi: 10.1080\/03610926.2010.535631","journal-title":"Commun Stat Theory Methods"},{"issue":"4 Pt 1","key":"1295_CR23","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/01.ju.0000137844.77524.97","volume":"172","author":"YC Chuang","year":"2004","unstructured":"Chuang YC, Yoshimura N, Huang CC, Chiang PH, Chancellor MB (2004) Intravesical botulinum toxin a administration produces analgesia against acetic acid induced bladder pain responses in rats. J Urol 172(4 Pt 1):1529\u20131532","journal-title":"J Urol"},{"issue":"3 Pt 1","key":"1295_CR24","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/S0022-5347(05)00322-8","volume":"175","author":"DE Rapp","year":"2006","unstructured":"Rapp DE, Turk KW, Bales GT, Cook SP (2006) Botulinum toxin type a inhibits calcitonin gene-related peptide release from isolated rat bladder. J Urol 175(3 Pt 1):1138\u20131142. doi: 10.1016\/S0022-5347(05)00322-8","journal-title":"J Urol"},{"issue":"Suppl 3","key":"1295_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/nau.22635","volume":"33","author":"C Chapple","year":"2014","unstructured":"Chapple C (2014) Chapter 2: pathophysiology of neurogenic detrusor overactivity and the symptom complex of overactive bladder. Neurourol Urodyn 33(Suppl 3):6\u201313. doi: 10.1002\/nau.22635","journal-title":"Neurourol Urodyn"},{"issue":"7","key":"1295_CR26","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/jnnp.2003.034702","volume":"75","author":"J Jankovic","year":"2004","unstructured":"Jankovic J (2004) Botulinum toxin in clinical practice. J Neurol Neurosurg Psychiatry 75(7):951\u2013957","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"1295_CR27","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.juro.2006.10.055","volume":"177","author":"KT McVary","year":"2007","unstructured":"McVary KT, Monnig W, Camps JL Jr, Young JM, Tseng LJ, van den Ende G (2007) Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial. J Urol 177(3):1071\u20131077. doi: 10.1016\/j.juro.2006.10.055","journal-title":"J Urol"},{"issue":"6","key":"1295_CR28","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.eururo.2008.01.075","volume":"53","author":"CG Stief","year":"2008","unstructured":"Stief CG, Porst H, Neuser D, Beneke M, Ulbrich E (2008) A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol 53(6):1236\u20131244. doi: 10.1016\/j.eururo.2008.01.075","journal-title":"Eur Urol"},{"issue":"5","key":"1295_CR29","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1464-410X.1994.tb07634.x","volume":"73","author":"CL Parsons","year":"1994","unstructured":"Parsons CL, Housley T, Schmidt JD, Lebow D (1994) Treatment of interstitial cystitis with intravesical heparin. Br J Urol 73(5):504\u2013507","journal-title":"Br J Urol"},{"issue":"3","key":"1295_CR30","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1097\/01.ju.0000083020.06212.3d","volume":"170","author":"GR Sant","year":"2003","unstructured":"Sant GR, Propert KJ, Hanno PM, Burks D, Culkin D, Diokno AC, Hardy C, Landis JR, Mayer R, Madigan R, Messing EM, Peters K, Theoharides TC, Warren J, Wein AJ, Steers W, Kusek JW, Nyberg LM, Interstitial Cystitis Clinical Trials G (2003) A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol 170(3):810\u2013815. doi: 10.1097\/01.ju.0000083020.06212.3d","journal-title":"J Urol"},{"key":"1295_CR31","doi-asserted-by":"publisher","unstructured":"Apostolidis A, Popat R, Yiangou Y, Cockayne D, Ford AP, Davis JB, Dasgupta P, Fowler CJ, Anand P (2005) Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urology 174(3):977\u2013982; discussion 982\u2013973. doi: 10.1097\/01.ju.0000169481.42259.54","DOI":"10.1097\/01.ju.0000169481.42259.54"},{"issue":"1","key":"1295_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.eururo.2008.05.007","volume":"56","author":"YC Chuang","year":"2009","unstructured":"Chuang YC, Yoshimura N, Huang CC, Wu M, Chiang PH, Chancellor MB (2009) Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats. Eur Urol 56(1):159\u2013166. doi: 10.1016\/j.eururo.2008.05.007","journal-title":"Eur Urol"},{"issue":"5","key":"1295_CR33","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1016\/j.juro.2007.06.044","volume":"178","author":"O Yokoyama","year":"2007","unstructured":"Yokoyama O, Miwa Y, Oyama N, Aoki Y, Ito H, Akino H (2007) Antimuscarinic drug inhibits detrusor overactivity induced by topical application of prostaglandin E2 to the urethra with a decrease in urethral pressure. J Urol 178(5):2208\u20132212. doi: 10.1016\/j.juro.2007.06.044","journal-title":"J Urol"},{"issue":"7521","key":"1295_CR34","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","volume":"331","author":"DM Caldwell","year":"2005","unstructured":"Caldwell DM, Ades AE, Higgins JP (2005) Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ 331(7521):897\u2013900. doi: 10.1136\/bmj.331.7521.897","journal-title":"BMJ"},{"issue":"8","key":"1295_CR35","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1503\/cmaj.081086","volume":"181","author":"JP Ioannidis","year":"2009","unstructured":"Ioannidis JP (2009) Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. Can Med Assoc J 181(8):488\u2013493. doi: 10.1503\/cmaj.081086","journal-title":"Can Med Assoc J"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-016-1295-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-016-1295-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-016-1295-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T08:02:10Z","timestamp":1559376130000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-016-1295-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,30]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["1295"],"URL":"https:\/\/doi.org\/10.1007\/s11255-016-1295-y","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,30]]}}}